| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015142 |
| Receipt No. | R000017320 |
| Official scientific title of the study | Reference Interval for Clearance and Excretion of Uric Acid in Japan |
| Date of disclosure of the study information | 2014/10/01 |
| Last modified on | 2017/03/14 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Reference Interval for Clearance and Excretion of Uric Acid in Japan | |
| Title of the study (Brief title) | RICE-U | |
| Region |
|
|
| Condition | ||||||
| Condition | Hyperuricemia | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | To clarify reference interval of urinary uric acid clearance test in Japanese adults |
| Basic objectives2 | Others |
| Basic objectives -Others | Reference interval |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | 60 min uric acid excretion, uric acid clearance |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Indoor workers
2) Age between 20 y.o. and 65 y.o 3) Consent in writing by the person |
|||
| Key exclusion criteria | 1) People who smoked 20 cigarettes or more per day
2) Who are receiving medication on a regular basis 3) People of women within one year after delivery or during pregnancy 4) People carrier hepatitis B virus, C hepatitis virus, human immunodeficiency virus 5) People who are planning or its received hospital treatment, surgery for acute disease within two weeks before the 60-minute method uric acid clearance inspection date 6) People who are scheduled to extreme exercise, muscle exertion of about can not talk during an activity for three days in front of the 60-minute method uric acid clearance inspection date 7)People who are scheduled overwork that prevents sleep time in three days in front of the 60-minute method uric acid clearance examination date, excessive stress, food and drink excessive 8) People you are planning that, or was taking drugs affecting the serum uric acid level in two weeks in front of the 60-minute method uric acid clearance inspection date |
|||
| Target sample size | 990 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Tsutani |
| Organization | National Hospital Organiation Awara Hospital |
| Division name | Directer |
| Address | 238-1 Kitagata, Awara, Fukui 910-4271, Japan |
| TEL | 0776-79-1211 |
| tsutani.hiroshi@awara-nho.jp | |
| Public contact | |
| Name of contact person | Junko Aoike |
| Organization | National Hospital Organiation Awara Hospital |
| Division name | Division of Clinical Research |
| Address | 238-1 Kitagata, Awara, Fukui 910-4271, Japan |
| TEL | 0776-79-1211 |
| Homepage URL | |
| 401CRC@hosp.go.jp | |
| Sponsor | |
| Institute | National Hospital Organiation Awara Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | National Hospital Organiation (NHO) multi-center clinical studies for evidence-based medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Prospective observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017320 |